HealthTech Innovation Days
Bringing Innovation to patient faster
Date: October 24-25, 2023 in Paris and October 27 only in virtual
Event Venue: At the Healthtech space in Paris, Palais Brongniart – 16 Pl. de la Bourse, 75002 Paris
Biocentury Platform : This year, we have the chance to collaborate with BioCentury! All selected companies participating in HTID are eligible for free trial access to BioCentury’s business intelligence platform!
About HealthTech For Care
The HealthTech For Care endowment fund, a non-profit organization, is designed to support and promote access to care for all and, more specifically, to new medical technologies and drugs. Within this framework, HealthTech For Care (HTFC) organizes various actions during the year, including HealthTech Innovation Days (HTID), 5th edition to come on October 24 and 25, 2023 October 2023, an event around the patient, HealthTech For Patients, 3rd edition in May 2023, a podcast Science For Care and also an Observatory that aims to defend a European policy that promotes cutting-edge medical innovation while ensuring fair access to care for all European patients.
About HealthTech Innovation Days
Under the High Patronage of Mr Emmanuel MACRON President of the French Republic, the HTID® event is a forum gathering stakeholders in the life sciences to meet and promote innovation to patients. Each year, HTID brings together over 800 participants in Paris: European innovative healthcare companies, international investors, large pharmaceutical companies, experts, scientist, physicians and others.
Webinar
Watch these webinars to discover the many exciting opportunities presented at the 2023 HealthTech Innovation Days event:
The speakers :
– Caroline de Mareuil-Villette, Founding Partner, ICOSA
– Max Herzberg, Chairman, Vidac Pharma
The speakers :
– Jenny Yip, Managing partner, Adjuvant capital
– Marion Soto, VP Business Development, Ariana pharma
The speakers :
– Marc Dechamps, Ceo of Bioxodes and board member of HealthTech For Care
– Marie Morice, head of Innovation & Digital, Amgen France
Tuesday, October 24th 2023
08:40am - 09:10am
09:10am - 10:20am
10:25am - 11:10am
11:25am - 12:10pm
Opening Ceremony
- Maryvonne HIANCE, President, HealthTech For Care
- Pierre COURTEILLE, CBO, Abivax
- Olivier BECHT, Minister Delegate for Foreign Trade, Economic Attractiveness, and French Nationals abroad.
- Shlomi KOFMAN, Vice President, the International Division
12:15pm - 12:35pm
Introducing : European fund for digital sovereignty
12:35pm - 01:30pm
01:30pm - 02:15pm
How macro-economic forces are shaping European healthcare innovation
- Christian PIERRET, French Former Minister of Industry (moderator)
- Dr. Dana BURDUJA, Head of Life Sciences and Health division, European Investment Bank
- Olga SOLOMON, Acting Director DPT, Medical Products and Innovation, DG Santé-European commission
- Bernard SPITZ, Chairman and Founder, BSC (Strategic Advisory)
02:20pm - 02:35pm
Crossed views: Supporting the growth of HealthTech companies to enhance innovation to the benefit of patients
- Suyin AERTS, Host event
- Guillaume MORELLI, Head of Listing France, Spain & Portugal, Euronext
- Gilles AVENARD, CEO, Acticor Biotech
02:40pm - 03:25pm
Innovative new licensing and M&A deals in healthtech
- Anne-France MOREAU, Life Sciences Partner, McDermott Will & Emery (moderator)
- Iordanis ARZIMANOGLOU, Programme Manager for Health and Biotechnology, European Innovation Council, European Commission
- Elena COLLUCCELLI-GUERIN, Managing Partner, Healthcare M&A, focus on mid cap, Rothschild & Co
- Antoine KHALLOUF, Director - Healthcare Group, Rothschild&Co
- Nicolas POIRIER, Chief Executive Officer & Chief Scientific Officer, OSE Immunotherapeutics
- Hubert CHAPERON, Chief Strategy Officer, Owkin
03:40pm - 04:15pm
From prevention to treatments together with patients
- Anaïs LE CORVEC, Co-Founder, Cliclab Transformative Agent (moderator)
- Alain HERRERA, Oncologist & Hematologist (moderator)
- Mia BAJRAMAGIC, IDF Europe Project Coordinator, Physician, Patient Advocate and a person living with Type one Diabetes
- Cristina NICULESCU, Senior Lifescience Specialist, European Investment Bank
04:20pm - 04:50pm
Virtual universe in healthtech, what does it bring to patients?
- Gabriela APIOU, Strategic Alliances Director, Massachusetts General Hospital Research Institute, Harvard Medical School (moderator)
- Alon WOLF, Professor of Mechanical and Biomedical Engineering, Technion Israel Institute of Technology
- Anca PETRE, Founder, Medrise Studio
- David BINDER, PhD, board-certified physician, Massachusetts General Hospital Orthopedic Spine Center
05:05pm - 05:50pm
Making the EU a more attractive playground now and for the future
- Stephanie LEOUZON, Managing Director, Stifel’s Global Healthcare Group (moderator)
- Siham IMANI, Executive Vice President Corporate Strategy & Business Development, Servier
- Rainer Westermann, chairman, Life Sciences Acceleration Alliance
- Cédric MOREAU, Partner, Sofinnova Partners
05:55pm - 07:05pm
07:05pm - 08:35pm
Wednesday, October 25th 2023
7:30am - 8:00am
8:00am - 9:00am
09:10am - 09:50am
Needs of European HealthTech companies and responses from industry and sector investors
- Philippe LOPES-FERNANDES, Executive Vice President, Chief Business Officer, Ipsen
- Pascal PRIGENT, CEO, GENFIT
- Lise ALTER, General Director, Agence Innovation Santé
09:55am - 10:30am
Unlocking opportunities in Asia for European healthtech companies
- Marc DECHAMPS, CEO, Bioxodes (moderator)
- Eric HALIOUA, CEO, PDC*Line Pharma
- Fleur PELLERIN, Founded Partner, Korelya Capital
- Eric DE LA FORTELLE, Managing Partner, Cathay Capital
- Philippe DE BACKER, Senior Partner, Newton BioCapital
10:45am - 11:45pm
11:50am - 12:05pm
Introducing : HERA missions (Health Emergency Preparedness and Response Authority)
- Olivier GIRARD, Head of Unit, Medical Counter-Measures, European Commission
12:10pm - 12:25pm
Introducing : European health position
- Audrey DERVELOY, President & Country Lead, Sanofi France
12:25pm - 01:25pm
01:25pm - 01:40pm
Introducing : Translating science into survival, reporting on the evolution of the immunotherapy hub
- Christoph HUBER, Professor emeritus hematology-oncology Johannes-Gutenberg-University, co-founder BioNTech SE and TRON GmbH
01:45pm - 02:30pm
Oncology : new tools to optimize therapeutic solution development from discovery to lifecycle management
- Thierry ANDRE, Medical Oncologist, PU-PH, chef de service, Hôpital Saint Antoine, APHP (moderator)
- Marc BUYSE, Chief Scientific Officer, IDDI and CluePoints
- Samer EL BAWAB, Global Head of Quantitative Pharmacology, Servier
- Mohammad AFSHAR, CEO, Ariana pharma
- Cyril SARRAUSTE DE MENTHIERE, Partner Patient, co-manager of MRCCR, subsidiary of « Patients en réseau » association
02:35pm - 03:15pm
Non violent therapies : Toposteric effect
- Max HERZBERG, Chairman, Vidac Pharma (moderator)
- Wolfgang LINK, Spanish National Research Council (CSIC), Institute of Biomedical Research Alberto Sols (IIBM)
- Laetitia LINARES, PhD MetaSarc, Metabolism and sarcoma IRCM, Institut de Recherche en Cancérologie de Montpellier INSERM U1194
- Lyora AHARONOV, co-founder and CEO, EMRIS Pharma
03:20pm - 03:55pm
Metabolic diseases: trends and funding issues-innovation
- Kyle Rose (moderator)
04:10pm - 04:45pm
Entrepreneurs’ strategies for success when navigating through rough waters
- Pierre COURTEILLE, CBO, Abivax (moderator)
- Benoit VAN DEN HOVE, CEO Euronext Brussels
- Enrique CLAVEROL-TINTURE, Head of the Medical Technologies Programme, European Innovation Council, European Commission
- Olivier TAELMAN, CEO, Nyxoah
04:50pm- 05:30pm
Strengthening diversity among all stakeholders: an opportunity and an imperative
- Anais LE CORVEC, Co-Founder, Cliclab Transformative Agent
- Beatrice CHEMLA, CEO & Co-founder, IMMA.Health
- Jenny YIP, Managing Partner, Adjuvant Capital
- Elisabeth DEL VALLE, Co-founder & CEO, Onalabs
- Jessica MATOUA-DAVID, Co-founder, Nemow group think tank
05:40pm - 06:00pm
06:05pm - 07:20pm